Comment by
ItsADonut on Aug 03, 2016 9:09am
This post has been removed in accordance with Community Policy
Comment by
ItsADonut on Aug 03, 2016 9:26am
This post has been removed in accordance with Community Policy
Comment by
select1011 on Aug 03, 2016 9:27am
This post has been removed in accordance with Community Policy
Comment by
InsiderTrader on Aug 29, 2016 9:16pm
So then you are pumping a company that you insisted before earnings that they would meet guidance. Sure bro, sure.
Comment by
junior22 on Oct 02, 2016 4:46pm
As I understand it, depending on the outcome of the lawsuits, payouts to U.S. investors could sink the company. Unfortunately, since I am not aware of any similar class actions planned in Canada and I doubt there would be any money left, Canadian investors would be left out in the cold. I believe this is also what happened in the case of Nortel.
Comment by
patenright11 on Oct 02, 2016 5:49pm
This post has been removed in accordance with Community Policy
Comment by
CookieMonster on Aug 03, 2016 10:08am
If you assume guidance reduction to $570 mln. Ebitda, CXR is trading at 7.0x Ev/ebitda. Fully discounted. Horizon Pharma, a good proxy is now trading at 8.2x ev/ebitda.
Comment by
LaticelnExile on Oct 17, 2016 6:46pm
This post has been removed in accordance with Community Policy
Comment by
PROtrading on Oct 17, 2016 7:22pm
Thank GOD! I was really hoping there were no investors that dumb! Can't even read material off TMX!